Company Filing History:
1 out of 15,471 
1 out of 52 
1 out of 14 Years Active: 2014-2017
Title: Ken Siu-Kwong Lau: Innovator in Glycan Dysregulation Research
Introduction
Ken Siu-Kwong Lau is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of glycan dysregulation, particularly in relation to autoimmune diseases. His innovative work has led to the development of methods and compositions aimed at preventing and treating these complex conditions.
Latest Patents
Ken Siu-Kwong Lau holds 2 patents that focus on methods and compositions for preventing and treating diseases related to glycan dysregulation. These patents are particularly directed towards autoimmune diseases, especially autoimmune demyelinating diseases. The contemplated compositions and methods are designed to prevent and/or treat these diseases, and they include aspects such as animal models and systems for screening compounds that may help in treatment or prevention.
Career Highlights
Throughout his career, Ken has worked with prestigious institutions, including the University of California and Mount Sinai Hospital Corporation. His research has been instrumental in advancing the understanding of glycan dysregulation and its implications for autoimmune diseases.
Collaborations
Ken has collaborated with esteemed colleagues such as Michael Demetriou and James W. Dennis. These partnerships have further enriched his research and contributed to the development of innovative solutions in his field.
Conclusion
Ken Siu-Kwong Lau is a prominent figure in the research of glycan dysregulation and autoimmune diseases. His patents and collaborations reflect his commitment to advancing medical science and improving treatment options for patients.